Cite
Loughlin AM, Chiuve SE, Reznor G, et al. Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database. Pharmacoepidemiol Drug Saf. 2021;30(12):1675-1686doi: 10.1002/pds.5333.
Loughlin, A. M., Chiuve, S. E., Reznor, G., Doherty, M., Missmer, S. A., Chomistek, A. K., & Enger, C. (2021). Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database. Pharmacoepidemiology and drug safety, 30(12), 1675-1686. https://doi.org/10.1002/pds.5333
Loughlin, Anita M, et al. "Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database." Pharmacoepidemiology and drug safety vol. 30,12 (2021): 1675-1686. doi: https://doi.org/10.1002/pds.5333
Loughlin AM, Chiuve SE, Reznor G, Doherty M, Missmer SA, Chomistek AK, Enger C. Method used to identify adenomyosis and potentially undiagnosed adenomyosis in a large, U.S. electronic health record database. Pharmacoepidemiol Drug Saf. 2021 Dec;30(12):1675-1686. doi: 10.1002/pds.5333. Epub 2021 Jul 29. PMID: 34292640.
Copy
Download .nbib